MicroRNA sequencing (miRNA-seq), a type of RNA-Seq, is the use of next-generation sequencing or massively parallel high-throughput DNA sequencing to sequence microRNAs, also called miRNAs. miRNA-seq differs from other forms of RNA-seq in that input material is often enriched for small RNAs. miRNA-seq allows researchers to examine tissue-specific expression patterns, disease associations, and isoforms of miRNAs, and to discover previously uncharacterized miRNAs. Evidence that dysregulated miRNAs play a role in diseases such as cancer has positioned miRNA-seq to potentially become an important tool in the future for diagnostics and prognostics as costs continue to decrease.

Market Analysis and Insights: Global MicroRNA Sequencing (miRNA-Seq) Market
The global MicroRNA Sequencing (miRNA-Seq) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global MicroRNA Sequencing (miRNA-Seq) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global MicroRNA Sequencing (miRNA-Seq) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global MicroRNA Sequencing (miRNA-Seq) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global MicroRNA Sequencing (miRNA-Seq) market.

Global MicroRNA Sequencing (miRNA-Seq) Scope and Market Size
MicroRNA Sequencing (miRNA-Seq) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global MicroRNA Sequencing (miRNA-Seq) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Sequencing by Synthesis
Ion Semiconductor Sequencing
SOLiD
Nanopore Sequencing

Segment by Application
Academic & Research Institutes
CROs

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Illumina
Thermo Fisher
Qiagen
Perkinelmer
Takara Bio
New England Biolabs
Norgen Biotek
Trilink Biotechnologies
Lexogen
Oxford Nanopore Technologies